News Releases

Nov 09, 2022
Lyra Therapeutics to Present at Upcoming Investor Conferences
WATERTOWN, Mass., Nov. 09, 2022 (GLOBE NEWSWIRE) -- Lyra Therapeutics, Inc. (Nasdaq: LYRA), a clinical-stage biotechnology company developing novel, integrated drug and delivery solutions for the localized treatment of patients with chronic rhinosinusitis (CRS), today announced that Maria Palasis,
Additional Formats
Displaying 1 - 10 of 25
Print Page
Email Alerts
RSS Feeds
Contact IR
Search
Back to Top